GSK3B and colorectal carcinoma: Indeed, the knockdown of IGF-1R inhibited human CRC (HT-29 and SW620) cell growth by blocking the activation of downstream PI3K/AKT signaling, which, in turn, contributed to the activation of GSK3β.